The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic retinopathy who have previously responded to at least 2 intravitreal ...

The integration of artificial intelligence (AI) into fundus cameras presents a significant opportunity for market growth. AI algorithms demonstrate high accuracy in detecting diseases like diabetic ...

If you're living with diabetes, you're probably aware of its effects on your blood sugar and general health. But did you know ...

If you care about diabetes, please read studies about Vitamin D and type 2 diabetes, and to people with diabetes, some fruits ...

The secret to a successful cataract surgery in diabetics lies in making informed decisions. Instead of being influenced by ...

Diabetic Retinopathy and Glaucoma are two retinal diseases that are a major cause of blindness. Regular Screening for early disease detection has been a highly labor - and resource- intensive task.

Key trends include advanced multicolor laser adoption and increased outpatient treatments. Challenges include reimbursement issues and competition from alternative therapies. Leading players like ...

Aim Retinal oxygen metabolism is thought to be affected in diabetic retinopathy. The aim of this study was to test whether retinal vessel oxygen saturation is different in patients with diabetic ...

The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

“Susvimo is a compelling new treatment for patients at risk of vision loss from progression of diabetic retinopathy,” said vitreoretinal surgeon, Carl Awh, M.D., Tennessee Retina, Tennessee.

The prospective deal supports Avant and Ainnova's broader goal: to deliver accessible, preventive health screening tools that combine retinal imaging, vital sign analysis, and machine learning ...